(Q30577548)

25 June 2017

title

Measurement and clinical effect of grey matter pathology in multiple sclerosis (English)

1 reference

25 June 2017

0 references

0 references

0 references

1

Jeroen J G Geurts

1 reference

25 June 2017

author name string

Massimiliano Calabrese

series ordinal

2

1 reference

25 June 2017

Elizabeth Fisher

series ordinal

3

1 reference

25 June 2017

Richard A Rudick

series ordinal

4

1 reference

25 June 2017

publication date

1 December 2012

1 reference

25 June 2017

1 reference

25 June 2017

volume

11

1 reference

25 June 2017

issue

12

1 reference

25 June 2017

page(s)

1082-1092

1 reference

The distribution of plaques in the cerebrum in multiple sclerosis

25 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Cortical demyelination and diffuse white matter injury in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Subpial demyelination in the cerebral cortex of multiple sclerosis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Grey matter pathology in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Gray matter imaging in multiple sclerosis: what have we learned?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Defining the clinical course of multiple sclerosis: Results of an international survey

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Grey Matter Pathology in Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Widespread demyelination in the cerebellar cortex in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Extensive hippocampal demyelination in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Hypothalamic lesions in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Spinal cord gray matter demyelination in multiple sclerosis-a novel pattern of residual plaque morphology.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Substantial archaeocortical atrophy and neuronal loss in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Minimal neuropsychological assessment of MS patients: a consensus approach

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Neocortical neuronal, synaptic, and glial loss in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Cholinergic imbalance in the multiple sclerosis hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Meningeal inflammation is not associated with cortical demyelination in chronic multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Epstein-Barr virus in the multiple sclerosis brain: a controversial issue--report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

The pathology of multiple sclerosis is location-dependent: no significant complement activation is detected in purely cortical lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

The blood-brain barrier in cortical multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Inflammatory cortical demyelination in early multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

A case of multiple sclerosis presenting with inflammatory cortical demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Altered Glutamate Reuptake in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis Cortex: Correlation With Microglia Infiltration, Demyelination, and Neuronal and Synaptic Damage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Potassium channel KIR4.1 as an immune target in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Gray matter pathology in (chronic) MS: modern views on an early observation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Will the real multiple sclerosis please stand up?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Double inversion recovery imaging of the brain: initial experience and comparison with fluid attenuated inversion recovery imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Postmortem verification of MS cortical lesion detection with 3D DIR.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Does high-field MR imaging improve cortical lesion detection in multiple sclerosis?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Imaging the tip of the iceberg: visualization of cortical lesions in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Improved Identification of Intracortical Lesions in Multiple Sclerosis with Phase-Sensitive Inversion Recovery in Combination with Fast Double Inversion Recovery MR Imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Accumulation of cortical lesions in MS: relation with cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Cortical lesions in primary progressive multiple sclerosis: a 2-year longitudinal MR study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

T1 cortical hypointensities and their association with cognitive disability in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Identification and clinical impact of multiple sclerosis cortical lesions as assessed by routine 3T MR imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Intracortical lesions by 3T magnetic resonance imaging and correlation with cognitive impairment in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Focal cortical lesion detection in multiple sclerosis: 3 Tesla DIR versus 7 Tesla FLASH-T2.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Cortical lesions in radiologically isolated syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Magnetic resonance evidence of cortical onset of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Acute severe memory impairment as a presenting symptom of multiple sclerosis: a clinical case study with 3D double inversion recovery MR imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Association of Neocortical Volume Changes With Cognitive Deterioration in Relapsing-Remitting Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

In vivo MR imaging of hippocampal lesions in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Imaging outcomes for neuroprotection and repair in multiple sclerosis trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Brain atrophy in multiple sclerosis: what we know and would like to know

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Brain atrophy assessment in multiple sclerosis: importance and limitations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Measurement of brain and spinal cord atrophy by magnetic resonance imaging as a tool to monitor multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Gray matter atrophy in multiple sclerosis: a longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Multimodal image coregistration and partitioning--a unified framework.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Voxel-based morphometry–the methods

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Segmentation of brain magnetic resonance images for measurement of gray matter atrophy in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Normalized accurate measurement of longitudinal brain change.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Accurate, robust, and automated longitudinal and cross-sectional brain change analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

A Bayesian model of shape and appearance for subcortical brain segmentation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Unfolding the human hippocampus with high resolution structural and functional MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Evaluation of automated techniques for the quantification of grey matter atrophy in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

The reproducibility and sensitivity of brain tissue volume measurements derived from an SPM-based segmentation methodology.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Measuring the thickness of the human cerebral cortex from magnetic resonance images

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

CLADA: cortical longitudinal atrophy detection algorithm

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Regional hippocampal atrophy in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Gray and white matter volume changes in early RRMS: a 2-year longitudinal study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Regional gray matter atrophy in early primary progressive multiple sclerosis: a voxel-based morphometry study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Brain atrophy in clinically early relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Evidence of early cortical atrophy in MS: relevance to white matter changes and disability

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Regional grey matter atrophy in clinically isolated syndromes at presentation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Atrophy mainly affects the limbic system and the deep grey matter at the first stage of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

The predictive value of gray matter atrophy in clinically isolated syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Brain atrophy and lesion load in a large population of patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

The relationship between whole brain volume and disability in multiple sclerosis: a comparison of normalized gray vs. white matter with misclassification correction.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Gray matter atrophy is related to long-term disability in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Relating neocortical pathology to disability progression in multiple sclerosis using MRI

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis: a 5-year longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Effect of immunomodulatory medication on regional gray matter loss in relapsing-remitting multiple sclerosis--a longitudinal MRI study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

The association of intrathecal immunoglobulin synthesis and cortical lesions predicts disease activity in clinically isolated syndrome and early relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970230-2

7 January 2021

10.1016/S1474-4422(12)70230-2

Identifiers

DOI

1 reference

25 June 2017

1 reference